Schonfeld Strategic Advisors’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-290,416
| Closed | -$4.39M | – | 3233 |
|
2022
Q3 | $4.39M | Buy |
+290,416
| New | +$4.39M | 0.04% | 571 |
|
2022
Q1 | – | Sell |
-17,900
| Closed | -$126K | – | 2972 |
|
2021
Q4 | $126K | Buy |
+17,900
| New | +$126K | ﹤0.01% | 1775 |
|
2020
Q3 | – | Sell |
-27,256
| Closed | -$402K | – | 1703 |
|
2020
Q2 | $402K | Buy |
+27,256
| New | +$402K | 0.01% | 846 |
|
2020
Q1 | – | Sell |
-180,148
| Closed | -$4.35M | – | 1624 |
|
2019
Q4 | $4.35M | Buy |
180,148
+92,248
| +105% | +$2.23M | 0.11% | 216 |
|
2019
Q3 | $1.69M | Buy |
+87,900
| New | +$1.69M | 0.05% | 342 |
|
2017
Q4 | – | Sell |
-11,801
| Closed | -$574K | – | 906 |
|
2017
Q3 | $574K | Buy |
+11,801
| New | +$574K | 0.05% | 358 |
|
2017
Q2 | – | Sell |
-7,498
| Closed | -$340K | – | 816 |
|
2017
Q1 | $340K | Sell |
7,498
-34,096
| -82% | -$1.55M | 0.03% | 444 |
|
2016
Q4 | $1.58M | Buy |
41,594
+18,363
| +79% | +$695K | 0.2% | 148 |
|
2016
Q3 | $877K | Buy |
23,231
+11,241
| +94% | +$424K | 0.15% | 197 |
|
2016
Q2 | $211K | Buy |
+11,990
| New | +$211K | 0.05% | 374 |
|